A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer

Clinical trial NCT06503614 · RECRUITING

Trial details

NCT number: NCT06503614
Sponsor: John Sfakianos
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-muscle Invasive Bladder Cancer Non-Muscle Invasive Bladder Urothelial Carcinoma

Start date: 2025-02-24
Primary completion: 2027-12-22
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.